S100A10 and gastric adenocarcinoma: In addition, data from the Oncomine database further demonstrated that higher expression of S100A10 was observed in diffuse gastric adenocarcinoma, gastric adenocarcinoma, gastric intestinal type adenocarcinoma, gastric papillary adenocarcinoma, gastric tubular adenocarcinoma, and mucinous gastric adenocarcinoma (Figure 1F).